Screener
Synopsys SNPS Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by Synopsys in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.
The source filing: Synopsys’s 10-Q, filed May 27, 2026.
- Filed
- May 27, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000883241-26-000018
| Line item | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses Less Than 12 Continuous Months | Gross Unrealized Losses 12 Continuous Months or Longer | Estimated Fair Value(1) |
|---|---|---|---|---|---|
| U.S. Treasury, agency & T-bills | 1,645 | — | — | — | 1,645 |
| Total: | $198,078 | — | — | — | $198,078 |
| Short-term investments: | |||||
| U.S. Treasury, agency & T-bills | $5,656 | $5 | — | — | $5,661 |
| Municipal bonds | 23,442 | 23 | (51) | — | 23,414 |
| Corporate debt securities | 42,697 | 98 | (81) | — | 42,714 |
| Other | 177 | — | — | — | 177 |
| Total: | $71,972 | $126 | $(132) | — | $71,966 |
Item 1. Financial Statements
FAQ
- What is Synopsys's cumulative cost basis?
- Synopsys (SNPS) reported cumulative cost basis of $71.97M in Q1 2026.
- How has Synopsys's cumulative cost basis changed year-over-year?
- Synopsys's cumulative cost basis decreased by 50.2% year-over-year, from $144.43M to $71.97M.
- What is the long-term trend for Synopsys's cumulative cost basis?
- Over 4 years (2021 to 2025), Synopsys's cumulative cost basis has grown at a -16.3% compound annual growth rate (CAGR), from $148.2M to $72.73M.
Ask your AI about Synopsys's cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude